CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $91,671,669
- in 32 filings, $73.3M under 10b5-1 plans
Net −$91,671,669. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Leproust Emily M. −$76.4M Chief Executive Officer sold 43% of stake
- Finn Patrick John −$6.8M President and COO sold 16% of stake
- Green Paula −$2.6M SVP of Human Resources sold 23% of stake
- Cho Dennis −$2.6M Reporting owner sold 17% of stake
- Laponis Adam −$2.6M Chief Financial Officer sold 12% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | Finn Patrick John President and COO | Sale | −12,752 | $103.69 | $1.3M | 221,161 |
| 2026-11-16 | Finn Patrick John President and COO | Grant or award | +18,206 | 239,367 | ||
| 2026-11-12 | Finn Patrick John President and COO | Grant or award | +53,635 | 233,913 | ||
| 2026-11-03 | Finn Patrick John President and COO | Sale | −2,565 | $135.40 | $347K | 180,278 |
| 2026-10-23 | Finn Patrick John President and COO | Sale | −2,245 | $134.59 | $302K | 182,843 |
| 2026-10-02 | Finn Patrick John President and COO | Sale | −25,714 | $188.88 | $4.9M | 185,088 |
| 2026-08-21 | Finn Patrick John President and COO | Sale | −4,046 | $139.07 | $563K | 210,802 |
| 2026-08-18 | Finn Patrick John President and COO | Exercise or conversion 10b5-1 | +23,355 | $67.85 | $1.6M | 293,033 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −33,354 | $115.90 | $3.9M | 259,679 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −10,420 | $116.82 | $1.2M | 249,259 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −8,868 | $117.70 | $1.0M | 240,391 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −4,500 | $119.04 | $536K | 235,891 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −12,917 | $119.86 | $1.5M | 222,974 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −6,296 | $121.01 | $762K | 216,678 |
| 2026-08-18 | Finn Patrick John President and COO | Sale 10b5-1 | −2,000 | $122.58 | $245K | 214,678 |
| 2026-08-18 | Finn Patrick John President and COO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −23,355 | 0 | ||
| 2026-08-03 | Finn Patrick John President and COO | Sale | −2,888 | $85.32 | $246K | 269,678 |
| 2026-07-23 | Finn Patrick John President and COO | Sale | −2,238 | $93.89 | $210K | 272,566 |
| 2026-05-21 | Finn Patrick John President and COO | Sale | −4,160 | $53.26 | $222K | 274,804 |
| 2026-05-04 | Finn Patrick John President and COO | Sale | −2,844 | $57.15 | $163K | 278,964 |
Page 1 of 4 · 76 trades